loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering CCDC 710249, HCl salt

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 80ALKERMES INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11241425

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3137

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

02

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11241425

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3137

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

03

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11241425

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3137

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

04

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11241425

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3137

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

05

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11185541

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3140

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

06

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11185541

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3140

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

07

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11185541

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3140

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

08

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11185541

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3140

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

09

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11793805

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3734

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank

10

arrow
26th North American ISSX
Not Confirmed
arrow
26th North American ISSX
Not Confirmed

OLANZAPINE; SAMIDORPHAN L-MALATE

US Patent Number : 11793805

Drug Substance Claim :

Drug Product Claim :

Application Number : 213378

Patent Use Code : U-3734

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-23

blank